✉news BusinessBusiness first seen 2 d ago, last 2 d ago, peak #19
Scinai signs $5.1 million CDMO development and manufacturing deal
Original: Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement
Scinai Immunotherapeutics has signed an agreement worth $5.1 million for development and clinical manufacturing services, expanding its contract development and manufacturing organization (CDMO) business. The deal marks a further step in the company's push to grow revenue through contract services alongside its drug development pipeline. Details about the client have not been disclosed.
Why now: Scinai's new contract signals growing commercial traction for its CDMO business, which matters to investors tracking the company's revenue growth.
Evidence
- Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement · PR Newswire
API: https://socialmediatrends-api.osmike.com/v1/trends/2103850